CuraFi
GhostCuraFi's blog covers infusion and specialty drug cost management for public payors such as Medicaid plans, mixing data analysis of high-cost, low-utilization drugs with FDA biosimilar news and explainers. Readers get practical context on drug spend trends and how plans can manage expensive therapies.